UK Markets closed

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
41.08+2.29 (+5.90%)
At close: 4:00PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3151.80
52-week low 335.05
50-day moving average 343.52
200-day moving average 374.21

Share statistics

Avg vol (3-month) 3646.12k
Avg vol (10-day) 3689.94k
Shares outstanding 5186.22M
Implied shares outstanding 6N/A
Float 880.57M
% held by insiders 155.92%
% held by institutions 123.46%
Shares short (27 May 2021) 42.95M
Short ratio (27 May 2021) 42.54
Short % of float (27 May 2021) 43.91%
Short % of shares outstanding (27 May 2021) 41.59%
Shares short (prior month 29 Apr 2021) 41.94M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin -264.21%
Operating margin (ttm)-273.27%

Management effectiveness

Return on assets (ttm)-10.17%
Return on equity (ttm)-38.63%

Income statement

Revenue (ttm)48.87M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)-11.40%
Gross profit (ttm)34.75M
EBITDA -127.73M
Net income avi to common (ttm)-129.12M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.33B
Total cash per share (mrq)7.34
Total debt (mrq)55.28M
Total debt/equity (mrq)7.77
Current ratio (mrq)5.61
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)522.4M
Levered free cash flow (ttm)57.92M